Cellegy Appoints Dr. Daniel Azarnoff Vice President Clinical and Regulatory Affairs.FOSTER CITY, Calif.--(BW HealthWire)--Oct. 13, 1997--Cellegy Pharmaceuticals Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CLGY) Monday announced it had appointed Daniel Azarnoff, M.D., as vice president, clinical and regulatory affairs Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs professionals usually have responsibility for the following general areas: Azarnoff, a distinguished scientist and retired president of research and development at G.D. Searle and Co., a leading multinational pharmaceutical subsidiary of Monsanto, has been acting as a consultant to Cellegy since February 1997. Commenting on the appointment, K. Michael Forrest, Cellegy's president and chief executive officer, said: "We are delighted to have a person of Dan Azarnoff's stature and expertise join the Cellegy management team. Dan has provided valuable advice and guidance to the company over the last several months while working with us on the regulatory strategies for our transdermal testosterone gel product. "In our industry, navigating the road to clinical and regulatory success requires careful planning and an intimate knowledge of the turns. Dr. Azarnoff has been down this road many times." Azarnoff has spent many years working within the health sciences area including 16 years at the University of Kansas The University of Kansas (often referred to as KU or just Kansas) is an institution of higher learning in Lawrence, Kansas. The main campus resides atop Mount Oread. Medical Center where he was a distinguished professor of medicine and pharmacology, as well as the director of the clinical pharmacology Clinical pharmacology is the science of drugs and their clinical use. It is underpinned by the basic science of pharmacology, with added focus on the application of pharmacological principles and methods in the real world. - toxicology center. In addition to his medical career, Azarnoff spent eight years at G.D. Searle and Co., where he served as president of research & development, as well as chief scientific and medical officer. For the last several years he has been an industry consultant specializing in clinical and regulatory matters. Azarnoff will continue to dedicate a portion of his time to his consulting activities. Azarnoff has received many distinguished awards and honors, including recognition as a Markle Scholar in Medicine, a Burroughs Wellcome Scholar in clinical pharmacology, a Fulbright Scholar and a fellow of several prominent scientific medical organizations, including the American Association of Pharmaceutical Scientists, the New York Academy of Sciences The New York Academy of Sciences is the third oldest scientific society in the United States. An independent, non-profit organization with more than 25,000 members in 140 countries, the Academy’s mission is to advance understanding of science and technology. , the American College of Physicians The American College of Physicians (ACP) is a national organization of doctors of internal medicine (internists), physicians who specialize in the prevention, detection and treatment of illnesses in adults. and the American Association for the Advancement of Science American Association for the Advancement of Science (AAAS), private organization devoted to furthering the work of scientists and improving the effectiveness of science in the promotion of human welfare. . Azarnoff is also a member of the Institute of Medicine of the National Academy of Sciences and has published numerous scientific articles in addition to serving on the editorial boards of several journals and as editor of several books. Azarnoff has also been a member of advisory and expert committees within the Food and Drug Administration, the World Health Organization, the American Medical Association American Medical Association (AMA), professional physicians' organization (founded 1847). Its goals are to protect the interests of American physicians, advance public health, and support the growth of medical science. , the National Academy of Sciences and National Institutes of Health, advising them on drug and drug development policy. Cellegy Pharmaceuticals is engaged in the development of prescription drugs and cosmeceutical cos·me·ceu·ti·cal n. A cosmetic that has or is purported to have medicinal properties. products based upon its patented topical and transdermal delivery technologies. CONTACT: Cellegy Pharmaceuticals Inc., Foster City Richard Juelis/K. Michael Forrest, 650/524-1600 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion